Narcotic Addiction Clinical Trial
Official title:
A Randomized Controlled Trial of Auricular Acupuncture to Facilitate Outpatient Opioid Weaning
Verified date | March 2019 |
Source | Vanderbilt University Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is to compare two groups undergoing opioid weaning as ordered by their referring physicians. One group will undergo the standard opioid weaning process and the other group will have the addition of the NADA Protocol to the weaning process.
Status | Terminated |
Enrollment | 16 |
Est. completion date | February 25, 2019 |
Est. primary completion date | January 14, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Adults aged 18 and older - Referral to the VUMC Interventional Pain Clinic for opioid weaning and discontinuation. Exclusion Criteria: |
Country | Name | City | State |
---|---|---|---|
United States | Vanderbilt University Medical Center | Nashville | Tennessee |
Lead Sponsor | Collaborator |
---|---|
Vanderbilt University Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline in clinical institute narcotic assessment scale (CINA) for withdrawal | time from beginning of opioid withdrawal intervention to opioid cessation(approximately 6 months) | ||
Secondary | Off-opioids rate | time from beginning of opioid withdrawal intervention to opioid cessation(approximately 6 months) | ||
Secondary | Change from baseline assessment of psychological distress of weaning, assessed using the Hospital Anxiety and Depression Scale (HADS) | 9 months | ||
Secondary | Time to cessation of opioids | time from of beginning of opioid withdrawal intervention to opioid cessation (approximately 6 months) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01965704 -
Can Ondansetron Prevent Neonatal Abstinence Syndrome (NAS) in Babies Born to Narcotic-dependent Women
|
Phase 2 |